Related Experiment Video
Updated: Sep 2, 2025
An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
Published on: June 12, 2013
Understanding the role of alternative macrophage phenotypes in human atherosclerosis
Kenji Kawai1, Aimee E Vozenilek1, Rika Kawakami1
1Department of Cardiovascular Pathology, CVPath Institute, Gaithersburg, MD, USA.
Insights
Macrophages play a key role in atherosclerosis. Targeting specific macrophage subtypes offers a promising new strategy for treating this leading cause of heart disease.
Area of Science:
- Cardiovascular Research
- Immunology
- Cell Biology
Background:
- Ischemic heart disease, driven by atherosclerosis, remains a global health crisis.
- Current treatments for atherosclerosis primarily focus on lipid reduction and managing comorbidities.
- The role of macrophages in atherosclerosis has evolved from general involvement to understanding specific subtypes.
Purpose of the Study:
- To comprehensively review macrophage phenotypes in atherosclerosis.
- To elucidate how distinct macrophage subtypes influence atherosclerotic plaque development and progression.
- To explore novel therapeutic strategies targeting specific macrophage subsets.
Main Methods:
- Review of existing literature on macrophage biology in atherosclerosis.
- Analysis of cellular and molecular mechanisms underlying macrophage phenotype diversity.
- Synthesis of data on the functional outcomes of different macrophage subtypes in atherosclerotic lesions.
Main Results:
- Macrophage differentiation is influenced by signals within atherosclerotic lesions, leading to diverse subsets.
- Specific macrophage phenotypes exhibit distinct roles, including promoting lesion development, healing, and regression.
- Understanding these varied functions is crucial for developing targeted therapies.
Conclusions:
- Targeting specific macrophage phenotypes presents a novel and promising therapeutic avenue for atherosclerosis.
- Further research into macrophage subtypes can unlock new treatment strategies for cardiovascular disease.
- Personalized approaches based on macrophage profiles may revolutionize atherosclerosis management.
Introduction:
Atherosclerosis-based ischemic heart disease is still the primary cause of death throughout the world. Over the past decades there has been no significant changes in the therapeutic approaches to atherosclerosis, which are mainly based on lipid lowering therapies and management of comorbid conditions such as diabetes and hypertension. The involvement of macrophages in atherosclerosis has been recognized for decades. More recently, a more detailed and sophisticated understanding of their various phenotypes and roles in the atherosclerotic process has been recognized. This new data is revealing how specific subtypes of macrophage-induced inflammation may have distinct effects on atherosclerosis progression and may provide new approaches for treatment, based upon targeting of specific macrophage subtypes.
Areas Covered:
We will comprehensively review the spectrum of macrophage phenotypes and how they contribute to atherosclerotic plaque development and progression.
Expert Opinion:
Various signals derived from atherosclerotic lesions drive macrophages into complex subsets with different gene expression profiles, phenotypes, and functions, not all of which are understood. Macrophage phenotypes include those that enhance, heal, and regress the atherosclerotic lesions though various mechanisms. Targeting of specific macrophage phenotypes may provide a promising and novel approach to prevent atherosclerosis progression.
More Related Videos
Related Concept Videos
01:38Inflammation
01:30Atherosclerosis I: Introduction
01:26Coronary Artery Disease II: Pathophysiology
01:26Atherosclerosis III: Management